IN SILICO MOLECULAR PROPERTIES PREDICTION OF COMPOUNDS FROM CARICA PAPAYA LEAF EXTRACT

ABHIGNA NARA; KUDAGI BL; SUBASH KR; SRIHARSHA RAYAM

doi:10.22159/ajpcr.2020.v13i11.39297

Authors

ABHIGNA NARA Department of Pharmacology, Narayana Medical College and Research Institute, Nellore, Andhra Pradesh, India.
KUDAGI BL Department of Pharmacology, Narayana Medical College and Research Institute, Nellore, Andhra Pradesh, India.
SUBASH KR Department of Pharmacology, Sri Venkateswara Institute of Medical Sciences -SPMC(W), Tirupati, Andhra Pradesh, India.
SRIHARSHA RAYAM Department of Pharmacology, Narayana Medical College and Research Institute, Nellore, Andhra Pradesh, India.

DOI:

https://doi.org/10.22159/ajpcr.2020.v13i11.39297

Keywords:

Carica papaya, In silico, Pharmacokinetics, Toxicology

Abstract

Objectives: The objectives of the study were to analyze the scientific rationale and possible pharmacokinetic properties of certain biologically active compounds from Carica papaya leaf extract in silico.

Methods: This study was investigated on web-based tools PUBCHEM to extract the chemical structure followed by authentication and validation with chemical formula. The 2-dimensional structures are further converted to 3-dimensional (3D) structure with CHEMSKETCH software, the derived 3D structures are then screened for molecular properties and druglikeness score followed by absorption, distribution, metabolism, elimination, and toxicity through admetSAR software. The reports are analyzed and predicted for possible drug like compound in leaf extract of papaya.

Results: The results obtained indicate that the compounds screened papain, chymopapain, quercetin, and protocatechuic acid had the druglikeness score −0.93, −0.05, + 0.93, and +0.74, respectively. On acute toxicity prediction, quercetin belonged to Class II and other compounds belonged to Class III.

Conclusion: The study confirms the among the compounds screened for in silico druglikeness and adsorption, distribution, metabolism, excretion, and toxicity profile quercetin a flavonoid can be possibly developed as effective anti-dengue compound.

Downloads

Download data is not yet available.

References

Huet J, Looze Y, Bartik K, Raussens V, Wintjens R, Boussard P. Structural characterization of the papaya cysteine proteinases at low pH. Biochem Biophys Res Commun 2006;341:620-6.

de Maria PD, Sinisterra JV, Tsai SW, Alcantara AR. Carica papaya lipase (CPL): An emerging and versatile biocatalyst. Biotechnol Adv 2006;24:493-9.

Okeniyi JA, Ogunlesi TA, Oyelami OA, Adeyemi LA. Effectiveness of dried Carica papaya seeds against human intestinal parasitosis: A pilot study. J Med Food 2007;10:194-6.

Adebowale A, Garnesan AP, Prasad RN. Papaya (Carica papaya) consumption is unsafe in pregnancy: Fact or fable? Scientific evaluation of a common belief in some parts of Asia using a rat model. Br J Nutr 2002;88:199-203.

Russell W, Burch RL. The Principles of Humane Experimental Technique. Vol. 1. London, UK: Methuen Press; 1959. p. 10-32.

Fan Y, Cheng M, Cheng Y. The reformation in our organic chemistry classes caused by the excellent software ACD/ChemSketch. J Guangzhou Univ 2002;6:G434.

Walters WP, Murcko MA. Prediction of drug-likeness. Adv Drug Deliv Rev 2002;54:255-71.

Clark DE, Pickett SD. Computational methods for the prediction of drug-likeness. Drug Discov Today 2000;5:49-58.

Srivastava AK, Singh VK. Carica Papaya-a herbal medicine. Int J Res Stud Biosci 2016;4:19-25.

Roshan A, Verma NK, Gupta A. A brief study on Carica Papaya-a review. Int J Curr Trends Pharm Res 2014;2:541-50.

Manohar PR. Papaya, dengue fever and ayurveda. Anc Sci Life 2013;32:131-3.

Senthilvel P, Lavanya P, Kumar KM, Swetha R, Anitha P, Bag S, et al. Flavonoid from Carica papaya inhibits NS2B-NS3 protease and prevents dengue 2 viral assembly. Bioinformation 2013;9:889-95.

Subenthiran S, Choon TC, Cheong KC, Thayan R, Teck MB, Muniandy PK, et al. Carica papaya leaves juice significantly accelerates the rate of increase in platelet count among patients with dengue fever and dengue haemorrhagic fever. Evid Based Complement Alternat Med 2013;2013:616737.